PubRank

James F Markmann

Author PubWeight™ 87.24‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Homeostatic proliferation is a barrier to transplantation tolerance. Nat Med 2003 4.12
2 Therapeutic siRNA silencing in inflammatory monocytes in mice. Nat Biotechnol 2011 3.95
3 Structural and functional abnormalities in the islets isolated from type 2 diabetic subjects. Diabetes 2004 2.22
4 Predicting outcome after liver transplantation: utility of the model for end-stage liver disease and a newly derived discrimination function. Transplantation 2004 2.13
5 Survival following liver transplantation from non-heart-beating donors. Ann Surg 2004 1.96
6 Renal function after orthotopic liver transplantation is predicted by duration of pretransplantation creatinine elevation. Liver Transpl 2005 1.87
7 Lack of benefit of pre-transplant locoregional hepatic therapy for hepatocellular cancer in the current MELD era. Liver Transpl 2006 1.72
8 Geographic inequity in access to livers for transplantation. Transplantation 2011 1.71
9 Accelerated memory cell homeostasis during T cell depletion and approaches to overcome it. J Immunol 2006 1.51
10 GITR Blockade Facilitates Treg Mediated Allograft Survival. Transplantation 2009 1.48
11 Cutting edge: transplant tolerance induced by anti-CD45RB requires B lymphocytes. J Immunol 2007 1.47
12 Immune rejection after pancreatic islet cell transplantation: in vivo dual contrast-enhanced MR imaging in a mouse model. Radiology 2012 1.41
13 Promotion of allograft survival by CD4+CD25+ regulatory T cells: evidence for in vivo inhibition of effector cell proliferation. J Immunol 2004 1.34
14 Elevated portal vein drug levels of sirolimus and tacrolimus in islet transplant recipients: local immunosuppression or islet toxicity? Transplantation 2003 1.32
15 {beta}-Cell function following human islet transplantation for type 1 diabetes. Diabetes 2005 1.28
16 Pretransplant model to predict posttransplant survival in liver transplant patients. Ann Surg 2002 1.22
17 Allograft survival following adult-to-adult living donor liver transplantation. Am J Transplant 2004 1.20
18 Expansion and conversion of human pancreatic ductal cells into insulin-secreting endocrine cells. Elife 2013 1.19
19 Islet cell hormonal responses to hypoglycemia after human islet transplantation for type 1 diabetes. Diabetes 2005 1.16
20 TGF-β-producing regulatory B cells induce regulatory T cells and promote transplantation tolerance. Eur J Immunol 2014 1.15
21 Transplantation for type I diabetes: comparison of vascularized whole-organ pancreas with isolated pancreatic islets. Ann Surg 2004 1.15
22 Glycemic thresholds for activation of counterregulatory hormone and symptom responses in islet transplant recipients. J Clin Endocrinol Metab 2006 1.04
23 Antibody-induced transplantation tolerance that is dependent on thymus-derived regulatory T cells. J Immunol 2006 1.03
24 Factors differentially correlated with the outcome of liver transplantation in hcv+ and HCV- recipients. Transplantation 2004 1.02
25 Comparison of open, laparoscopic, and hand-assisted approaches to live-donor nephrectomy. Transplantation 2002 0.99
26 Resistance to anti-CD45RB-induced tolerance in NOD mice: mechanisms involved. Transpl Int 2004 0.99
27 The outcome of liver grafts procured from hepatitis C-positive donors. Transplantation 2002 0.98
28 HLA sensitization in islet transplantation. Clin Transpl 2006 0.97
29 Evidence for allograft rejection in an islet transplant recipient and effect on beta-cell secretory capacity. J Clin Endocrinol Metab 2007 0.96
30 The faltering solid organ donor pool in the United States (2001-2010). World J Surg 2012 0.95
31 Toward further expansion of the organ pool for adult liver recipients: splitting the cadaveric liver into right and left lobes. Transplantation 2002 0.94
32 Early kidney dysfunction post liver transplantation predicts late chronic kidney disease. Transplantation 2004 0.93
33 Salvage of nonmaturing native fistulas by using angioplasty. Radiology 2006 0.92
34 IL-21 is an antitolerogenic cytokine of the late-phase alloimmune response. Diabetes 2011 0.92
35 CD25+ immunoregulatory CD4 T cells mediate acquired central transplantation tolerance. J Immunol 2003 0.91
36 Expanded-criteria donor kidneys: a single-center clinical and short-term financial analysis--cause for concern in retransplantation. Transplantation 2004 0.91
37 Effect of glucagon-like peptide-1 on beta- and alpha-cell function in isolated islet and whole pancreas transplant recipients. J Clin Endocrinol Metab 2008 0.90
38 Inhibition of ICAM-1/LFA-1 interactions prevents B-cell-dependent anti-CD45RB-induced transplantation tolerance. Transplantation 2008 0.89
39 Pancreatic-derived factor (FAM3B), a novel islet cytokine, induces apoptosis of insulin-secreting beta-cells. Diabetes 2003 0.88
40 Transduction of human islets with pseudotyped lentiviral vectors. Hum Gene Ther 2004 0.88
41 A Bridge to Somewhere: 25-day Survival After Pig-to-Baboon Liver Xenotransplantation. Ann Surg 2016 0.87
42 Donor age and cold ischemia interact to produce inferior 90-day liver allograft survival. Transplantation 2008 0.86
43 Survival among pediatric liver transplant recipients: impact of segmental grafts. Liver Transpl 2004 0.86
44 Inotuzumab ozogamicin murine analog-mediated B-cell depletion reduces anti-islet allo- and autoimmune responses. Diabetes 2011 0.85
45 Inhibition of transplantation tolerance by immune senescence is reversed by endocrine modulation. Sci Transl Med 2011 0.84
46 Appendicitis among liver transplant recipients. Liver Transpl 2005 0.83
47 Islet alone versus islet after kidney transplantation: metabolic outcomes and islet graft survival. Transplantation 2009 0.83
48 Contrast-enhanced MR angiography for evaluation of vascular complications of the pancreatic transplant. Radiographics 2005 0.81
49 T-reg mediated suppression of the allograft response in the draining lymph node. Transplantation 2006 0.81
50 Role of B cells in tolerance induction. Curr Opin Organ Transplant 2015 0.81
51 Effects of sirolimus vs. calcineurin inhibitors on renal dysfunction after orthotopic liver transplantation. Clin Transplant 2007 0.81
52 Induction of diabetes with signs of autoimmunity in primates by the injection of multiple-low-dose streptozotocin. Biochem Biophys Res Commun 2011 0.80
53 Increased transfusion-free survival following auxiliary pig liver xenotransplantation. Xenotransplantation 2014 0.80
54 Avenues for immunomodulation and graft protection by gene therapy in transplantation. Transpl Int 2006 0.79
55 A prospective, randomized comparison of bovine carotid artery and expanded polytetrafluoroethylene for permanent hemodialysis vascular access. J Vasc Surg 2011 0.79
56 Blockade of GITR-GITRL interaction maintains Treg function to prolong allograft survival. Eur J Immunol 2010 0.79
57 Alemtuzumab in kidney-transplant recipients. N Engl J Med 2011 0.79
58 Report from IPITA-TTS Opinion Leaders Meeting on the Future of β-Cell Replacement. Transplantation 2016 0.79
59 Treatment of obstructive nephroureteral clot with a rheolytic mechanical thrombectomy device. J Vasc Interv Radiol 2003 0.79
60 Comparison of whole organ pancreas and isolated islet transplantation for type 1 diabetes. Adv Surg 2005 0.78
61 Regulatory CD4+CD25+T cells in prevention of allograft rejection. Front Biosci 2003 0.78
62 B-cell depletion improves islet allograft survival with anti-CD45RB. Cell Transplant 2012 0.78
63 A direct comparison of rejection by CD8 and CD4 T cells in a transgenic model of allotransplantation. Arch Immunol Ther Exp (Warsz) 2008 0.78
64 Market competition influences renal transplantation risk and outcomes. Ann Surg 2014 0.78
65 Successful long-term management of invasive cerebral fungal infection following liver transplantation. Mycoses 2015 0.77
66 Immunosenescence and immune response in organ transplantation. Int Rev Immunol 2013 0.77
67 Progress toward antibody-induced transplantation tolerance. Crit Rev Immunol 2007 0.77
68 Age-related differences in hepatic ischemia/reperfusion: gene activation, liver injury, and protective effect of melatonin. J Surg Res 2012 0.77
69 Availability of suitable islet donors in the United States. Transplantation 2007 0.77
70 Impact of Pretransplant Bridging Locoregional Therapy for Patients With Hepatocellular Carcinoma Within Milan Criteria Undergoing Liver Transplantation: Analysis of 3601 Patients from the US Multicenter HCC Transplant Consortium. Ann Surg 2017 0.77
71 Historical overview of transplantation. Cold Spring Harb Perspect Med 2013 0.76
72 An immunosufficient murine model for the study of human islets. Xenotransplantation 2014 0.76
73 Pharmacologically regulated regeneration of functional human pancreatic islets. Mol Ther 2005 0.76
74 Hyperlipidemia due to biliary stricture after living-donor liver transplantation. Transplantation 2011 0.76
75 Mechanisms of regulatory T cell counter-regulation by innate immunity. Transplant Rev (Orlando) 2013 0.76
76 Elevated levels of interferon-γ production by memory T cells do not promote transplant tolerance resistance in aged recipients. PLoS One 2013 0.75
77 Prophylaxis of hepatitis B infection in solid organ transplant recipients. Therap Adv Gastroenterol 2013 0.75
78 Generation of adaptive regulatory T cells by alloantigen is required for some but not all transplant tolerance protocols. Transplantation 2011 0.75
79 The Clearer BENEFITS of Belatacept. N Engl J Med 2016 0.75
80 Transplantation: Are calcineurin inhibitors safer than mTOR inhibitors? Nat Rev Nephrol 2012 0.75
81 Tolerance: it's in your blood. Clin Immunol 2008 0.75
82 Peritransplant energy changes and their correlation to outcome after human liver transplantation. Transplantation 2017 0.75
83 Monitoring of Allogeneic Islet Grafts in Nonhuman Primates Using MRI. Transplantation 2015 0.75
84 Is Donor Service Area Market Competition Associated With Organ Procurement Organization Performance? Transplantation 2016 0.75
85 Interpreting Outcomes in DCDD Liver Transplantation: First Report of the Multi-Center IDOL Consortium. Transplantation 2017 0.75
86 Left accessory hepatic artery damage by a misplaced gastric band in a deceased liver donor. Transplantation 2013 0.75
87 Renal allograft rupture: a strategy for graft preservation. Transplantation 2011 0.75
88 Temporal Analysis of Market Competition and Density in Renal Transplantation Volume and Outcome. Transplantation 2016 0.75
89 Kidney transplantation at the University of Pennsylvania: 1998-2008. Clin Transpl 2009 0.75
90 Protein S deficiency in a living liver donor. Transpl Int 2011 0.75
91 Image of the month. Portal vein gas associated with pneumatosis intestinalis. Arch Surg 2012 0.75
92 Erratum. National Institutes of Health-Sponsored Clinical Islet Transplantation Consortium Phase 3 Trial: Manufacture of a Complex Cellular Product at Eight Processing Facilities. Diabetes 2016;65:3418-3428. Diabetes 2017 0.75